Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers. 1988

V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
Clinical Pharmacology Unit (CDRI), Seth G. S. Medical College, Bombay, India.

The effect of the menstrual cycle on antipyrine pharmacokinetics was studied in 11 normal, healthy Indian female volunteers. Antipyrine half-life, apparent volume of distribution, clearance and AUC were calculated by standard methods. Results indicated that in females, antipyrine half-life was significantly longer on day 5 as compared with that on days 15 and 21 of the menstrual cycle. It appears that hormonal changes during the menstrual cycle affect the pharmacokinetics of drugs in normal healthy females.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
November 1980, Digestive diseases and sciences,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
May 1990, Clinical science (London, England : 1979),
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
April 1990, Journal of clinical pharmacy and therapeutics,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
January 1995, Journal of psychopharmacology (Oxford, England),
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
March 1987, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
August 2002, Therapeutic drug monitoring,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
May 1992, Xenobiotica; the fate of foreign compounds in biological systems,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
October 1991, Clinical pharmacology and therapeutics,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
August 2002, Journal of clinical psychopharmacology,
V K Nayak, and N A Kshirsagar, and N K Desai, and R S Satoskar
December 2001, Journal of clinical pharmacology,
Copied contents to your clipboard!